[1] Maschmeyer G,Helweg-Larsen J,Pagano L,et al.ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients[J].J Antimicrob Chemother,2016 ,71(9):2405-2413. [2] Lane MA,Devine ST,McDonald JR.High‐risk antimicrobial prescriptions among ambulatory patients on warfarin[J].J Clin Pharm Ther,2012 ,37(2):157-160. [3] Anderson Jr FA,Spencer FA.Risk factors for venous thromboem-bolism[J].Circulation,2003,107(23 Suppl 1):9-16. [4] Saleh MN,Bussel JB,Cheng G,et al.Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia:results of the long-term,open-label EXTEND study[J].Blood,2013,121(3):537-545. [5] Kim KJ,Baek IW,Yoon CH,et al.Thrombotic risk in patients with immune thrombocytopenia and its association with antiphospholipid antibodies[J].Br J Haematol,2013 ,161(5):706-714. [6] Chinese Medical Association Respiratory Diseases Pulmonary Embolism and Pulmonary Vascular Diseases Group,Chinese Medical Association Respiratory Physician Branch Pulmonary Embolism and Pulmonary Bascular Disease Working Committee,National Pulmonary Embolism and Pulmonary Vascular Disease Prevention and Treatment Group.The guideline of pulmonary thrombosis diagnosis and treatment[J].Natl Med J China(中华医学杂志),2018,98(14):1060-1087. [7] Wei J,Jin H,Chai YF,et al.CYP2C9 and VKORC1 gene detection to guide the clinical study of individualized warfarin anticoagulation therapy in patients with acute pulmonary thromboembolism[J/OL].Chin J Crit Care Med(中华重症医学),Electron Ed,2016,9(2):91-95. [8] Yu JJ,Kuang Y,Wang H,et al.Research status of the interaction between warfarin and antibacterial drugs and its mechanism[J].Chin J Clin Pharmacol(中国临床药理学杂志),2016,32(24):2319-2322,2336. [9] Hosaka K,Saito S,Ishii T,et al.Safety of fondaparinux versus enoxaparin after TKA in Japanese patients[J].Orthopedics,2013,36(4):e428-e433. [10] Gu YL,Ge WH.Yu F.Research progress on the interaction between warfarin and antibacterial drugs[J].Chin J Hosp Pharm(中国医院药学杂志),2013,33(20):1708-1710. [11] Drug-induced liver disease group of the Chinese Society of Hepatology.Guidelines for the diagnosis and treatment of drug-induced liver injury[J].J Clin Hepatol,2017,20(2):1-18 [12] Zhang Y,You PC,Zheng QS.Investigation and analysis of 115 cases of warfarin clinical application[J].Chinese Journal of Pharmacovigilance(中国药物警戒),2011,8(9):524-527. [13] Zhao YQ,Gao J,Xie C.A case of pharmaceutical care of a patient with atrial fibrillation taking warfarin anticoagulant therapy[J].Chinese Journal of Pharmacovigilance(中国药物警戒),2011,8(10):632-633. |